Polycystic Ovary Syndrome (PCOS) and Metabolic Syndrome: Long-term Health Implications for Women

Review Paper | 2026 | Volume 1 | Issue 1 | Page 20-21

Dr. Ashik Rahman, Assistant Professor, Department of Gynecology, MMIMSR, Ambala

Dr. Apoorba Solnaki, Assistant Professor, Department of Gynecology, MMIMSR, Ambala

Abstract:

Background: Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder among women of reproductive age. While its immediate symptoms often involve menstrual irregularities and hyperandrogenism, its long-term association with Metabolic Syndrome (MetS)—including insulin resistance, dyslipidemia, and visceral obesity—presents a significant cardiovascular risk.

Objective: This review explores the pathophysiological link between PCOS and Metabolic Syndrome and discusses the life-course health risks, ranging from Type 2 Diabetes to Non-alcoholic Fatty Liver Disease (NAFLD).

Methods: A review of cross-sectional and longitudinal studies was conducted, focusing on the diagnostic criteria (Rotterdam vs. AE-PCOS Society) and the prevalence of metabolic comorbidities in PCOS phenotypes.

Discussion: The cornerstone of the PCOS-MetS link is Hyperinsulinemia, which not only exacerbates androgen production in the ovaries but also drives systemic metabolic dysfunction. Women with PCOS are found to have a four-fold higher risk of developing Type 2 Diabetes Mellitus (T2DM) and a significantly increased prevalence of obstructive sleep apnea and hypertension compared to age-matched controls. The review emphasizes that lean women with PCOS are also at risk, suggesting that "metabolic health" is compromised regardless of Body Mass Index (BMI). Furthermore, the long-term risk of Endometrial Hyperplasia and Cardiovascular Disease (CVD) necessitates early screening and lifestyle interventions beyond fertility treatments.

Conclusion: PCOS should be managed as a lifelong metabolic condition rather than a transient gynecological concern. Early screening for glucose intolerance and lipid profiles, combined with metformin therapy and structured lifestyle modifications, is essential to mitigate the long-term morbidity associated with Metabolic Syndrome in this population.

Keywords: PCOS, Metabolic Syndrome, Insulin Resistance, Type 2 Diabetes, Hyperandrogenism, Cardiovascular Risk, Women's Health.